Filing Details
- Accession Number:
- 0001209191-18-029011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 19:06:21
- Reporting Period:
- 2018-05-07
- Accepted Time:
- 2018-05-09 19:06:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1624527 | L Alan Hoffman | 800 W. Olympic Blvd Suite 406 Los Angeles CA 90015 | Evp, Global Corporate Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-07 | 26,157 | $112.96 | 1,882 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-07 | 75,448 | $30.44 | 77,330 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-07 | 20,332 | $112.96 | 56,998 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-05-07 | 27,328 | $112.96 | 29,670 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2018-05-07 | 75,448 | $0.00 | 75,448 | $30.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,508 | 2018-03-02 | 2025-03-02 | No | 4 | M | Direct |
Footnotes
- The reporting person received 27,788 shares of common stock upon the net exercise of 75,448 stock appreciation rights ("SARS"). The reporting person forfeited 20,332 shares of common stock underlying the SARS in payment of the exercise price and 27,328 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 7, 2018 of $112.96.
Billionaire Hedge Funds
